Zhang et al. [29] showed roles for TP53 in the down-regulation of gluconeogenesis both in vitro in colon and liver cancer cells and in vivo, by down regulation the gene expression of PCK and G6PC, the rate limiting enzymes of gluconeogenesis. This evidence concerns the gene TP53 and liver cancer.